1α,25-(OH)2-D3 promotes the autophagy during osteoclastogenesis by enhancing RANKL-RANK-TRAF6 signaling
- PMID: 34780049
- DOI: 10.1007/s11626-021-00632-z
1α,25-(OH)2-D3 promotes the autophagy during osteoclastogenesis by enhancing RANKL-RANK-TRAF6 signaling
Abstract
As the active form of vitamin D3, 1α,25-(OH)2-D3 promotes receptor activator for nuclear factor-κB ligand (RANKL)-induced autophagy in osteoclast precursors (OCPs). However, the relationship between 1α,25-(OH)2-D3 and RANKL signaling is still unknown. This study aimed to explore whether 1α,25-(OH)2-D3 regulates OCP autophagy and osteoclastogenesis through RANKL signaling. Our results showed that 1α,25-(OH)2-D3 directly decreased OCP autophagy while significantly enhancing the ability of RANKL to promote OCP autophagy. Moreover, 1α,25-(OH)2-D3 not only promoted the expression of key signaling proteins in OCPs induced by RANKL but also enhanced the coimmunoprecipitation levels of RANK and TRAF6. Notably, 1α,25-(OH)2-D3 significantly enhanced the autophagic activity and osteoclast differentiation of RANK-positive OCPs but did not affect the autophagic activity or osteoclast differentiation of RANK-negative OCPs. More importantly, 1α,25-(OH)2-D3 had no effect on autophagy or osteoclastogenesis in TRAF6-silenced OCPs. Overall, 1α,25-(OH)2-D3 could upregulate RANKL-RANK-TRAF6 signaling in OCPs, thereby promoting OCP autophagy and osteoclastogenesis.
Keywords: 1α,25-(OH)2-D3; Autophagy; Osteoclast; RANK; RANKL; TRAF6.
© 2021. The Society for In Vitro Biology.
Similar articles
-
Autophagy exerts pivotal roles in regulatory effects of 1α,25-(OH)2D3 on the osteoclastogenesis.Biochem Biophys Res Commun. 2019 Apr 16;511(4):869-874. doi: 10.1016/j.bbrc.2019.02.114. Epub 2019 Mar 5. Biochem Biophys Res Commun. 2019. PMID: 30850163
-
Curcumin suppresses RANKL-induced osteoclast precursor autophagy in osteoclastogenesis by inhibiting RANK signaling and downstream JNK-BCL2-Beclin1 pathway.Biomed J. 2024 Feb;47(1):100605. doi: 10.1016/j.bj.2023.100605. Epub 2023 May 11. Biomed J. 2024. PMID: 37179010 Free PMC article.
-
Phosphorylation of BCL2 at the Ser70 site mediates RANKL-induced osteoclast precursor autophagy and osteoclastogenesis.Mol Med. 2022 Feb 19;28(1):22. doi: 10.1186/s10020-022-00449-w. Mol Med. 2022. PMID: 35183115 Free PMC article.
-
Current Understanding of RANK Signaling in Osteoclast Differentiation and Maturation.Mol Cells. 2017 Oct;40(10):706-713. doi: 10.14348/molcells.2017.0225. Epub 2017 Oct 17. Mol Cells. 2017. PMID: 29047262 Free PMC article. Review.
-
Mechanism of inhibitory action of eldecalcitol, an active vitamin D analog, on bone resorption in vivo.J Steroid Biochem Mol Biol. 2013 Jul;136:171-4. doi: 10.1016/j.jsbmb.2012.11.010. Epub 2012 Dec 5. J Steroid Biochem Mol Biol. 2013. PMID: 23220095 Review.
Cited by
-
Vitamin D3 affects browning of white adipocytes by regulating autophagy via PI3K/Akt/mTOR/p53 signaling in vitro and in vivo.Apoptosis. 2022 Dec;27(11-12):992-1003. doi: 10.1007/s10495-022-01765-6. Epub 2022 Sep 9. Apoptosis. 2022. PMID: 36083402
-
Osteoimmunology: Interactions With the Immune System in Spinal Fusion.Int J Spine Surg. 2023 Dec 27;17(S3):S9-S17. doi: 10.14444/8556. Int J Spine Surg. 2023. PMID: 38050073 Free PMC article.
-
Denosumab Can Prevent Collapse in Patients with Early-Stage Steroid-Induced Osteonecrosis of the Femoral Head by Inhibiting Osteoclasts and Autophagy.Orthop Surg. 2023 Jan;15(1):256-265. doi: 10.1111/os.13584. Epub 2022 Nov 18. Orthop Surg. 2023. PMID: 36398455 Free PMC article.
References
-
- Arai A, Kim S, Goldshteyn V, Kim T, Park NH, Wang CY, Kim RH (2019) Beclin1 modulates bone homeostasis by regulating osteoclast and chondrocyte differentiation. J Bone Miner Res 34:1753–1766 - DOI
-
- Armstrong AP, Tometsko ME, Glaccum M, Sutherland CL, Cosman D, Dougall WCA (2002) RANK/TRAF6-dependent signal transduction pathway is essential for osteoclast cytoskeletal organization and resorptive function. J Biol Chem 277:44347–44356 - DOI
-
- Chen H, Fang C, Zhi X, Song S, Gu Y, Chen X, Cui J, Hu Y, Weng W, Zhou Q, Wang Y, Wang Y, Jiang H, Li X, Cao L, Chen X, Su J (2020) Neobavaisoflavone inhibits osteoclastogenesis through blocking RANKL signalling-mediated TRAF6 and c-Src recruitment and NF-κB, MAPK and Akt pathways. J Cell Mol Med 24:9067–9084 - DOI
-
- Chen K, Yan Z, Wang Y, Yang Y, Cai M, Huang C, Li B, Yang M, Zhou X, Wei X, Yang C, Chen Z, Zhai X, Li M (2020) Shikonin mitigates ovariectomy-induced bone loss and RANKL-induced osteoclastogenesis via TRAF6-mediated signaling pathways. Biomed Pharmacother 126:110067 - DOI
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials